Ischemia D007511

Description

A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.   MeSH

Hierarchy View

Subtype Terms (2)

Infarction
447 drugs (221 approved, 226 experimental)

No-Reflow Phenomenon
5 approved drugs


Phase 4 Indicated Drugs (172)

Key: D007511 (87) Subtype (85)

Phase 3 Indicated Drugs (155)

Key: D007511 (91) Subtype (64)

Phase 2 Indicated Drugs (176)

Key: D007511 (115) Subtype (61)


Organization Involved with Phase 4 Indications (243)

Key: D007511 (96) Subtype (147)

Aalborg University

Aarhus University

Abbott

Academy of Athens

Ain Shams University

Ajou University

Allegheny Health Network

Ankara Yildirim Beyazıt University

Assiut University

AstraZeneca

Athens Red Cross Hospital

Azienda Sanitaria Ospedaliera

Baskent University

Beijing Bozhiyin T&S Co., Ltd.

Ben Gurion University

Biosense Webster, Inc.

Boehringer Ingelheim

Burnasyan Federal Medical Biophysical Center

Campus Bio-Medico University

Capital Medical University

Careggi Hospital

Catholic University of Sacred Heart, Rome

Cedars-Sinai Medical Center

Central South University

Chang Gung University

Charles University

Chiangmai University

China Academy of Chinese Medical Sciences

China Medical University

Chinese Academy of Medical Sciences

Chinese Center of Diseases Control and Prevention

Chonnam National University

Clalit Health Services

CLI Foundation

Clinical Institute of the Brain, Russia

Clinica Universidad de Navarra

Dalian Medical University

Dalian Zhen-Ao Bio-Tech Co., Ltd.

Department of Veteran Affairs

Dong-A University

Duke University

East Carolina University

Eisai

Eli Lilly

Erciyes University

Evangelismos Hospital

Ever Neuro Pharma GmbH

Federal University of Rio Grande do Sul

Federation of Associations of Hospital Doctors on Internal Medicine (FADOI) Foundation

Fengtian Hospital

First Hospital of Jilin University

Florida Atlantic University

Fudan University

Fundacja Ośrodek Badań Medycznych

General Electric

General Hospital of Chinese Armed Police Forces

Gennimatas Hospital, Athens

Georgetown University

Gilead Sciences

Government of China

Green Valley Group of China

Guangdong Provincial Hospital of Traditional Chinese Medicine

Guangzhou Medical University

Guangzhou Recomgen Biotech Co., Ltd.

Guangzhou University

Gyeongsang University

Hallym University

Hamilton Health Sciences Corporation

Harvard University

Heart Center of Indianapolis

Hebei University

Hoosier Cancer Research Network

Hospital Sao Domingos

Hospital Universitario Ramon y Cajal

Huazhong University

Human Stem Cell Institute, Russia

Humboldt University

Icahn School of Medicine at Mount Sinai

Imam Abdulrahman Bin Faisal University

Imperial College London

I.M. Sechenov First Moscow State Medical University

Inha University

Inje University

Inova Health System

Instituto Dante Pazzanese de Cardiologia

Instituto Mexicano del Seguro Social

Intermountain Health Care

Intermountain Heart Institute

Isala Clinics, Zwolle, The Netherlands

Istanbul University

Istituto Clinico Sant'Ambrogio

Jessenius Faculty of Medicine

Jiangsu Kanion Pharmaceutical Co., Ltd

Jiao Tong University

Jinan University

Jinling Hospital

Karolinska Institute

Katholieke Universiteit Leuven

Kobe University

Korea University

Krakowskie Centrum Kardiologii Inwazyjnej, Elektroterapii i Angiologii Carint Scanmed Sp. z o.o

Kumamoto University

Kyoto Prefectural University of Medicine

Kyoto University

Kyung Hee University

Lantheus Medical Imaging

Laval University

LifeBridge Health

Loyola University

Lund University

Maastricht University

Mansoura University

McMaster University

Medical Center of South Arkansas

Medical University of Vienna

Medical University of Warsaw

Melbourne Health

Mid America Heart Institute

Misericordia and Dolce Hospital

Mitsubishi Tanabe

Nanjing Medical University

National Cerebral and Cardiovascular Center

National Institute of Neurological Disorders and Stroke (NINDS)

Neuro-Ophthalmologic Associates, PC

New York University

NHS Greater Glasgow and Clyde

Nicolaus Copernicus University

Norwegian University of Science and Technology

Novartis

Ohio State University

Orebro University

Osaka Acute Coronary Insufficiency Study Group

Osaka General Medical Center

Osaka University

Ospedale Maggiore, Novara

Ospedale Misericordia e Dolce, Prato

Otsuka

Peking University

Penza State University

People's Liberation Army of China

Pfizer

Platelet and Thrombosis Research L.L.C

Pontificia Universidad Catolica de Chile

Radboud University

R&D Cardiologie

Region Örebro County

Region Skane

Retina Macula Specialists of Miami, LLC

Richmond University

Rouen Normandy University

RUMCN

Rush University

Saint Luke's Health System

Sanofi

Sapienza University of Rome

Seoul National University

Shaheed Beheshti Medical University

Shandong University

Shanghai Xuhui District Central Hospital

Sheffield Hallam University

ShuGuang Hospital

Silesian University of Medicine

Soochow University

SOS Attaque Cérébrale

Spanish Society of Cardiology

St. Antonius Hospital, Nieuwegein

Sungkyunkwan University

Taichung Veterans General Hospital

Taipei Veteran General hospital

Teaching Hospital Královské Vinohrady (FNKV)

Technical University of Munich

Technion University

Techpool Bio-Pharma Co., Ltd.

Tel Aviv University

Temple University

The Baruch Padeh Medical Center, Poriya

The Cleveland Clinic

The Royal Wolverhampton NHS Trust

The University of Hong Kong

Tsinghua University

Universidad Carlos III Madrid

University Cardiology

University Hospital, Martin

Organization Involved with Phase 3 Indications (187)

Key: D007511 (102) Subtype (85)

Organization Involved with Phase 2 Indications (209)

Key: D007511 (144) Subtype (65)

Organization Involved with Other Experimental Indications (62)

Key: D007511 (40) Subtype (22)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.